JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Ladanyi
    Ladanyi
  2. Robson
    Robson
  3. Drilon
    Drilon
  4. Arcila
    Arcila
  5. Berger
    Berger
  6. Riely
    Riely
  7. Carlo
    Carlo
  8. Kris
    Kris
  9. Mandelker
    Mandelker
  10. Offin
    Offin

Groups

  1. Department of Medicine (21)
  2. Solid Tumor Oncology Division (20)
  3. Department of Pathology and Laboratory Medicine (14)
  4. GSK Faculty (14)
  5. Weinberg Fellows (11)
  6. Human Oncology and Pathogenesis Program (9)
  7. Population Sciences Research Program (9)
  8. Thoracic Oncology (9)
  9. Breast Medicine Service (8)
  10. Center for Pancreatic Cancer Research (8)
Search Within
  1. "2019"
Formats
  1. Journal Article (23)
Groups
  1. Department of Medicine (21)
  2. Solid Tumor Oncology Division (20)
  3. Department of Pathology and Laboratory Medicine (14)
  4. GSK Faculty (14)
  5. Weinberg Fellows (11)
  6. Human Oncology and Pathogenesis Program (9)

More Groups

People
  1. David Hyman (7)
  2. Marc Ladanyi (6)
  3. Mark Robson (6)
  4. Ahmet Zehir (5)
  5. Alexander Drilon (5)
  6. Jaclyn Hechtman (5)

More People

Years
  1. 2019 (23)
Publishers
  1. American Society of Clinical Oncology (23)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Endometrial cancers in BRCA1 or BRCA2 germline mutation carriers: Assessment of homologous recombination DNA repair defects
    Journal Article

    Smith, E. S.; Da Cruz Paula, A.; Cadoo, K. A.; Abu-Rustum, N. R.; Pei, X.; Brown, D. N.; Ferrando, L.; Sebastiao, A. P. M.; Riaz, N.; Robson, M. E.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer
    Journal Article

    Himoto, Y.; Veeraraghavan, H.; Zheng, J.; Zamarin, D.; Snyder, A.; Capanu, M.; Nougaret, S.; Vargas, H. A.; Shitano, F.; Callahan, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Combined PIK3CA and FGFR inhibition with alpelisib and infigratinib in patients with PIK3CA-mutant solid tumors, with or without FGFR alterations
    Journal Article

    Hyman, D. M.; Tran, B.; Paz-Ares, L.; Machiels, J. P.; Schellens, J. H.; Bedard, P. L.; Campone, M.; Cassier, P. A.; Sarantopoulos, J.; Vaishampayan, U.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • P2RY8-CRLF2 fusion–positive acute myeloid leukemia with myelodysplasia-related changes: Response to novel therapy
    Journal Article

    Aypar, U.; Taylor, J.; Garcia, J. S.; Momeni-Boroujeni, A.; Gao, Q.; Baik, J.; Londono, D.; Benayed, R.; Sigler, A.; Haddadin, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Atypical RAS mutations in metastatic colorectal cancer
    Journal Article

    Pietrantonio, F.; Yaeger, R.; Schrock, A. B.; Randon, G.; Romero-Cordoba, S.; Rossini, D.; Fucà, G.; Ross, J. S.; Kotani, D.; Madison, R.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer
    Journal Article

    Vokes, N. I.; Liu, D.; Ricciuti, B.; Jimenez-Aguilar, E.; Rizvi, H.; Dietlein, F.; He, M. X.; Margolis, C. A.; Elmarakeby, H. A.; Girshman, J.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma
    Journal Article

    Whitman, J.; Kardosh, A.; Diaz, L. Jr; Fong, L.; Hope, T.; Onodera, C.; Joseph, N.; Le, D.; Fisher, G.; Bergsland, E.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Pathogenic loss-of-function germline TERT mutations in patients with solid tumors
    Journal Article

    Walsh, M. F.; Sacca, R.; Wildman, T.; Amoroso, K.; Kennedy, J.; Zhang, L.; Birsoy, O.; Mandelker, D.; Steinsnyder, Z.; Latham, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using EndoPredict, an integrated 12-gene clinicomolecular assay
    Journal Article

    Soliman, H.; Flake, D. D. 2nd; Magliocco, A.; Robson, M.; Schwartzberg, L.; Sharma, P.; Brown, K.; Wehnelt, S.; Kronenwett, R.; Gutin, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology